866-897-8297

Call Is Confidential & Toll Free

Xtandi

Xtandi is an androgen receptor inhibitor for the treatment of castration-resistant prostate cancer. FDA approved on August 31, 2012.

Resitance to xtandi therapy has been observed. This may occurred due to an upregulation of NF-κB2/p52.

The most common adverse reactions (≥ 5%) are asthenia/fatigue, back pain, diarrhea, arthralgia, hot flush, peripheral edema, musculoskeletal pain, headache, upper respiratory infection, muscular weakness, dizziness, insomnia, lower respiratory infection, spinal cord compression and cauda equina syndrome, hematuria, paresthesia, anxiety, and hypertension.

Imprints


Drug: Xtandi
Strength: 40 Mg
Pill Imprint: ENZ
Color: White
Shape: Elliptical / Oval

View Images & Details

Drug: Xtandi
Strength: 40 Mg
Pill Imprint: MDV
Color: White
Shape: Capsule-shape

View Images & Details
Disclaimer: We strive to ensure that the content on pilladdictions.com is current and factual at the time it was written. However, because new information and discoveries are always becoming available, we are not making any representations or warranties with respect to this content. Please always rely on the guidance of your physician for information about the drugs you are taking and the impacts they may or may not have on your health.

Questions About Prescription Drug Addiction?

(888) 740-2069

Questions About Prescription Drug Addiction?